IKZF1 and leukemia: In summary, our study underscores the importance of leukemia subtype classification, characterization of IKZF1 alterations, and genomics-based analysis of cooperating lesions, in predicting the prognosis of pediatric patients with B-ALL undergoing MRD-directed therapy.